Searchable abstracts of presentations at key conferences in endocrinology

ea0020p237 | Bone/Calcium | ECE2009

Thin healthy women have a similar low bone mass as women with anorexia nervosa

Fernandez-Garcia Diego , Sebastian Arantzazu , Garcia-Aleman Jorge , Garcia-Almeida Jose Manuel , Tinahones Francisco

Association between anorexia nerviosa (AN) and low bone mass has been demonstrated. Bone loss associated with AN involve hormonal and nutritional impairments, though their exact contribution is not clearly established. We compare bone mass in AN patients with women of similar weight with no criteria for anorexia nervosa, and a third group of healthy, normal-weight, age-matched women. The study included 48 patients with AN (DSM-IV criteria), 22 healthy eumenorrheic women with l...

ea0016p4 | Adrenal | ECE2008

Might the response of cortisol to oral glucose tolerance test be used for the differential diagnosis of Cushing's syndrome and pseudo-Cushing's states?

De Martino Maria Cristina , De Leo Monica , Ochoa Arantzazu Sebastian , Auriemma Renata Simona , Galdiero Mariano , Lombardi Gaetano , Colao Annamaria , Pivonello Rosario

The pseudo-Cushing states (PCS) include several clinical conditions such as obesity, polycystic ovary syndrome, depression and alcoholism, characterized by physical features and abnormalities of hypothalamus–pituitary–adrenal axis similar to Cushing’s syndrome (CS). The differential diagnosis between CS and PCS is often complicated and requires several hormonal tests. The aim of this study is to evaluate the diagnostic accuracy of the cortisol response to the or...

ea0081ep1021 | Thyroid | ECE2022

Clinical experience with tyrosine kinase inhibitors in radioiodine-refractory differentiated thyroid cancer

Fernandez Valero Andrea , Damas-Fuentes Miguel , Montoro Jose Ignacio Marti nez , Vega Maria Molina , Doblas Isabel Mancha , Garcia Aleman Jorge , Ochoa Arantzazu Sebastian , Manuel Trigo Perez Jose , Jose Tinahones Madueno Francisco

Introduction: Differentiated thyroid cancer (DTC) represent 85- 90 % of all thyroid cancer cases. Most of these have an excellent prognosis with standard treatment. However, between 7 and 23% will develop distant metastases and, of these, more than 65% will become radioactive iodine-refractory. In some of these patients who are considered to be radioiodine-refractory with rapidly progressive or symptomatic disease, or in patients who are not candidates for other therapies, the...